Molecular insights into ago-allosteric modulation of the human glucagon-like peptide-1 receptor

The glucagon-like peptide-1 (GLP-1) receptor is a validated drug target for metabolic disorders. Ago-allosteric modulators are capable of acting both as agonists on their own and as efficacy enhancers of orthosteric ligands. However, the molecular details of ago-allosterism remain elusive. Here, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Zhaotong, Chen, Li-Nan, Ma, Honglei, Zhou, Qingtong, Zou, Xinyu, Ye, Chenyu, Dai, Antao, Liu, Qing, Huang, Wei, Sun, Xianqiang, Wang, Xi, Xu, Peiyu, Zhao, Lihua, Xia, Tian, Zhong, Wenge, Yang, Dehua, Eric Xu, H., Zhang, Yan, Wang, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213797/
https://www.ncbi.nlm.nih.gov/pubmed/34145245
http://dx.doi.org/10.1038/s41467-021-24058-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8213797/
https://www.ncbi.nlm.nih.gov/pubmed/34145245
http://dx.doi.org/10.1038/s41467-021-24058-z

Ejemplares similares